<!DOCTYPE html>
<!--[if lt IE 7]><html class="no-js ie6 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 7]><html class="no-js ie7 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 8]><html class="no-js ie8 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 9]><html class="no-js ie9 ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!<![endif]-->
<!--[if (gt IE 9)|(gt IEMobile 7)|!(IEMobile)|!(IE)]><!--><html class="no-js" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!--<![endif]-->
<head>
       
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"c2a5bf7b54","applicationID":"2502042","transactionName":"IlheTBRdCQ8DQxxWWg9DVVYSHRUWBF1aVmoSX19P","queueTime":0,"applicationTime":79,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta name="keywords" content="newsletter, biodefense, government contracting, infectious disease news, biotech events, partnering, mentoring" />
  <meta name="description" content="Government contracting can be daunting; here’s how to get started." />
  <meta name="geo.region" content="US" />
  <meta content="article" property="og:type" />
  <meta content="Getting started with federal contracting" property="og:title" />
  <meta content="Government contracting can be daunting; here’s how to get started." property="og:description" />
  <meta content="http://www.csc.com/dvc/blog/41185/93730-getting_started_with_federal_contracting" property="og:url" />
  <meta content="en-US" property="og:locale" />
  <meta content="Computer Sciences Corporation" property="og:site_name" />
  <link rel="canonical" href="93730-getting_started_with_federal_contracting.html" />
  <title>Getting started with federal contracting | CSC</title>

  <script type="text/javascript">
    var responsive=true ;
  </script>


    <script type="text/javascript">
      var responsive = true;
    </script>
    <!--[if lte IE 8]>
      <script type="text/javascript">responsive = false;</script>
    <![endif]-->
    <![if gt IE 8]>
    <meta name="viewport" content="initial-scale=1,maximum-scale=1,width=device-width" />
     <link href="../../../stylesheets/user/global-bundle-78733079cb421825fca5a903046c770c.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]>
    <!--[if lte IE 8]>
       <link href="../../../stylesheets/user/global_non_responsive-bundle-9ef563e134b588f9a45b5060ad4b78aa.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]-->
    

       <link href="../../../assets/public/comments-7c37505c1a6e388ce4e34a78fbb12494.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="../../../stylesheets/user/blogdetail-492cb34d506631f042187b0a924bc649.css" media="all" rel="stylesheet" type="text/css" />

    <![if gt IE 8]>
    <script src="../../../javascripts/user/global-bundle-8889b0584423b7383dba5816ff101fd5.js" type="text/javascript"></script>
    <![endif]>
    <!--[if lte IE 8]>
      <script src="../../../javascripts/user/global_non_responsive-bundle-8385e9848036be955101f89324885409.js" type="text/javascript"></script>
    <![endif]-->
    


  <!--[if lt IE 9]>
  <script src="../../../javascripts/user/printshiv-min-68e071550e9b2f652850bf54693181a1.js" type="text/javascript"></script>
  <!<![endif]-->

<script>
$csc().gigya.init("2_znZ6oKy7notCLVoNArGFVv8LPRNmj8f3YN1TN-Hxt0Q1xFL2-tD8kc84bP_jARhA");
</script>


  <script type="text/javascript">
    include_default_css = true;
    //translations
    ls_header = "CSC Live Search: Quick Results";
    ls_see = "Don't see what you're looking for?";
          ls_search = "Search all over";
    ls_results = "for more results";
    mn_navigation = "Navigation";
    mn_countrySelect = "Worldwide";
    mn_search = "Search";
  </script>

  
</head>
<body itemscope itemtype="http://schema.org/WebPage">
    <script src="../../../javascripts/user/mbox_js-min-c4e062b0e669784dee7d810bbaa1f418.js" type="text/javascript"></script>
  <script type="text/javascript">
          setupCampaignTracking();
          var s_code = null;
          var _gaq = null;
          visitorOrg = null;
          var db_err = null;
        </script>
    <script src="../../../javascripts/user/s_code-min-38fd02ddea4b57c76bed86493f62daa0.js" type="text/javascript"></script>
  
  <script type="text/javascript">
    var contentID = '';
    var zoneID = '';
    var contentTypeID = '';
    s.charSet="UTF-8";
    s.pageName="DVC LLC:Blogs:93730-Getting started with federal contracting";
    s.channel=window.location.hostname;
    s.products="93730";
    s.prop1="DVC LLC";
    s.prop2="DVC LLC:Blogs";
    s.prop3="DVC LLC:Blogs";
    s.prop8="Blogs";
    s.prop9="93730";
    s.prop10="1819";
    s.prop16="Managed Multipurpose Sites";
    s.prop19="";
    s.prop37="Zack Cannon";
    s.prop38="Awareness";
    s.eVar44 = "D=c38";
    contentID="93730";
    zoneID = "265";
    contentTypeID = "17";
    s.eVar9="D=c1";
    s.eVar10="D=c16";
    s.eVar11="Blogs";
    s.eVar12="D=pageName";
    s.eVar13="D=c19";
    s.eVar45="D=c37";
    s.eVar8="D=c9";
    
    s.prop12 = document.location.pathname + document.location.search;
    s.prop13="en-US";
    s.hier1 = document.location.hostname + ':' + s.pageName;
    createPublicPage(contentID,contentTypeID,s.prop8,zoneID,s.prop1,s.prop19);


    $csc().analytics.visitorOrg.buildPublic();
    _gaq = _gaq || [];
   setupGA(_gaq);

  </script>

  <script type="text/javascript">
  <!-- if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-') //-->
  </script>
  <noscript>
  <a href="http://www.omniture.com">
    <img src="http://computersciences.112.2o7.net/b/ss/csccom/1/H.15.1--NS/0" height="1" width="1" style="border: 0;" alt="" />
  </a>
  </noscript>

  <div class='mboxDefault'></div>
  <script type='text/javascript'>
  mboxCreate('page',
'entity.id=93730',
'entity.name=Getting started with federal contracting',
'entity.pageURL=/dvc/blog/41185/93730-getting_started_with_federal_contracting',
'entity.message=Government contracting can be daunting; here’s how to get started.',
'entity.categoryId=265',
'entity.content_type_id=17',
'entity.thumbnailURL=',
'entity.key_content_type=0',
'entity.locale=en-US',
'entity.listing=0',
'user.categoryId=265');
  </script>

<div id="viewporter">
  <header>
    <div id="mobiTagLine">
      <p>
        A global leader in providing technology enabled business solutions and services
      </p>
    </div>
    <div class="mainLogo">
      <a href="../../../index.html">
        <img src="../../../assets/new/logo.png" alt="CSC Logo - A global leader in providing technology enabled business solutions and services." /></a>
      <span class="globalHeadline">A global leader in providing technology enabled business solutions and services.</span>
    </div>
    <div id="country">
      <div><a href="javascript:void(0);" class="countryHide countrySelector">Worldwide</a><a id="countrySelector" class="countryHide countrySelector"></a></div>
      <div id="country-select" style="display:none;">
        <!--link href="/stylesheets/user/country_select_styles-min.css" rel="stylesheet" type="text/css" /-->
<div class="unitedstates">
	<a href="../../../index.html">United States</a>
</div>
<div class="australia">
	<a href="../../../au.html">Australia</a>
</div>
<div class="austria">
	<a href="../../../de.html">Austria</a>
</div>
<div class="belgium">
	<a href="../../../be.html">Belgium</a>
</div>
<div class="brazil">
	<a href="../../../br_pt.html">Brazil</a>
</div>
<div class="bulgaria">
	<a href="../../../eastern_europe.html">Bulgaria</a>
</div>
<div class="canada">
	<a href="../../../ca_en.html">Canada</a>
</div>
<div class="canada">
	<a href="../../../ca_fr.html">Canada [fr]</a>
</div>
<div class="chile">
	<a href="../../../cl.html">Chile</a>
</div>
<div class="china">
	<a href="../../../cn_cn.html">China</a>
</div>
<div class="czech">
	<a href="../../../eastern_europe.html">Czech Republic</a>
</div>
<div class="denmark">
	<a href="../../../dk.html">Denmark</a>
</div>
<div class="france">
	<a href="../../../fr.html">France</a>
</div>
<div class="germany">
	<a href="../../../de.html">Germany</a>
</div>
<div class="hongkong">
	<a href="../../../hk_en.html">Hong Kong</a>
</div>
<div class="india">
	<a href="../../../in.html">India</a>
</div>
<div class="italy">
	<a href="../../../it.html">Italy</a>
</div>
<div class="japan">
	<a href="../../../jp_jp.html">Japan</a>
</div>
<div class="korea">
	<a href="../../../kr.html">Korea</a>
</div>
<div class="lithuania">
	<a href="../../../lt.html">Lithuania</a>
</div>
<div class="luxembourg">
	<a href="../../../lu.html">Luxembourg</a>
</div>
<div class="malaysia">
	<a href="../../../my.html">Malaysia</a>
</div>
<div class="netherlands">
	<a href="../../../nl.html">Netherlands</a>
</div>
<div class="norway">
	<a href="../../../no.html">Norway</a>
</div>
<div class="poland">
	<a href="../../../eastern_europe.html">Poland</a>
</div>
<div class="portugal">
	<a href="../../../pt.html">Portugal</a>
</div>
<div class="romania">
	<a href="../../../eastern_europe.html">Romania</a>
</div>
<div class="singapore">
	<a href="../../../sg.html">Singapore</a>
</div>
<div class="slovakia">
	<a href="../../../eastern_europe.html">Slovakia</a>
</div>
<div class="southafrica">
	<a href="../../../za.html">South Africa</a>
</div>
<div class="spain">
	<a href="../../../es.html">Spain</a>
</div>
<div class="sweden">
	<a href="../../../se.html">Sweden</a>
</div>
<div class="switzerland">
	<a href="../../../de.html">Switzerland</a>
</div>
<div class="thailand">
	<a href="../../../th_en.html">Thailand</a>
</div>
<div class="unitedkingdom">
	<a href="../../../uk.html">United Kingdom</a>
</div>
<div class="vietnam">
	<a href="../../../vn_en.html">Vietnam</a>
</div>
<div class="vietnam">
	<a href="../../../vn_vn/index.html">Vietnam [vn]</a>
</div>

      </div>
      <div id="search">
        <form action="/search" method="get" name="searchForm" id="searchForm">
          <ul>
            <li>
              <input id="searchField" type="text" name="q"  />
              <input type="hidden" value="265" name="zone_id" id="gsa_zone_id" /><input type="hidden" value="en-US" name="locale" id="gsa_locale"/>
            </li>
            <li><input id="searchSubmit" class="hidden searchBtn" type="submit" /></li>
          </ul>
        </form>
      </div>
    </div>
    <nav id="mobiMainNav">
      <ul>
        <li id="mobiCountry"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiNav"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiSearchBtn"><a href="javascript:void(0);">&nbsp;</a> </li>
      </ul>
      <div id="mobileSearch" style="display:none">
        <div class="mobileSearchWrap">
          <input type="text" name="searchText" id="mobileSearchInput" /><a id="mobiSearchImage" href="javascript:void(0);"></a>
        </div>
      </div>
      <div id="mobileNav" style="display:none">
        <ul class="mobinav" style="">
	<li class="solutionsLink">
		<a href="../../offerings/44393.html">Services</a></li> 
	</li>
	<li class="successLink">
		<a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
	</li>
	<li class="insightsLink">
		<a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
	</li>
	<li class="contactLink">
		<a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
	</li>
	<li class="aboutLink">
		<a href="../../contact_us.html">Contact Us</a>
	</li>
</ul>
      </div>
    </nav>
    <div id="loginSection">
      <div id="visitor_login_section" class="loginSection unhidden"><a href="javascript:void(0);" id="nav_account_create" onclick="accountPopupWindow('account_create');">Register</a><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="javascript:void(0);" id="nav_account_login" onclick="accountPopupWindow('account_login');"><span class="nav_account_spacer">Login</span></a></div>
<div id="visitor_welcome_section" class="loginSection hidden"><span class="nav_account_spacer">Welcome,&nbsp;</span><label id="nav_edit_profile" style="cursor:pointer;" onclick="accountPopupWindow('editprofile');"><span id="visitor_name"></span></label><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="../../../utils/logout_visitor.html" id="nav_logout_visitor">Log&nbsp;Out</a></div>
    </div>
    <div class="wrapper">
  <nav id="globalNav">
    <ul id="nav">
      <li id="solutionsLink">
	<a href="../../offerings/44393.html">Services</a></li>
      <li id="successLink">
        <a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
      <li id="insightsLink">
        <a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
      <li id="contactLink">
        <a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
      <li id="aboutLink">
        <a href="../../contact_us.html">Contact Us</a>
      </li>
    </ul>
  </nav>
</div>
  </header>
  <div class="breadcrumbs wrapper" itemprop="breadcrumb">
    <ul class='breadCrumbs'> <li><a href='../../../index.html'>Home</a> / </li> <li><a href='../../../dvc.html'>DVC LLC</a> / </li> <li><a href='../41185.html'>DVC News Updates for Partners</a> / </li> <li>Getting started with federal contracting</li> </ul>
  </div>
  <nav class="mobiSecondaryNav">
    <ul>
      <li id="mobiBack"><a href="../41185.html">Back</a> </li>
      <li id="mobiBackLabel">&nbsp;</li>
      <li id="mobiMoreLinks"><a href="javascript:void(0);">More Links</a> </li>
    </ul>
  </nav>
  <div id="iscrollWrapper">
    <div class="scrollwrap">
      <!-- Content Start -->

      
<section id="mainContent" class="rightSideBar">
  <div class="wrapper">
    
    <!-- Share Bar Plugin DIV Container -->
<div id="gigyaButtons"></div>
<script type="text/javascript">
  $csc().gigya.showShareBar();
</script>
<!-- End Share Bar Code -->
    <article class="pageContent" itemprop="mainContentOfPage">
    <!-- Gigya Bar -->
    <article class="blogPost">
    <section>
      <h1>Getting started with federal contracting</h1>
      <time>2013-01-02</time>
      <p><h2><span style="font-weight: bold; color: #005884;">Feature: Getting Started with Government Contracting</span></h2>
<p><a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/"><img style="float: right; margin: 10px;" alt="Historic Federal Hall on Wall Street" src="http://assets1.csc.com/dvc/images/federal_hall.gif" height="199" width="300" /></a>You don’t know what you don’t know. This is particularly true in government contracting. The Federal market is large, but entry can be daunting due to the seemingly endless string of requirements and documentation.</p>
<p>So, where can you start? A variety of resources on government contracting are available online. Regional organizations, like the Fort Detrick Business Development Office (<a target="_blank" href="http://www.fdbdo.com/">FDBO</a>) and Tech Council of Maryland, and the U.S. General Services Administration (GSA) itself offer inexpensive introductory <a target="_blank" href="http://www.gsa.gov/portal/event/getEvents/future/category/22104/hostUri/portal">courses</a> periodically. Procurement fairs are useful to connect with larger companies that hold prime contracts. Prime contractors often work with subcontractors to complete various pieces of the work, and they can help you learn the lingo. Plus, many of them are required to work with <a target="_blank" href="http://www.sba.gov/">small or otherwise disadvantaged businesses</a> to meet government requirements.</p>
<p>Before you start your government contracting journey, you’ll need to register with <a target="_blank" href="88290-have_you_met_sam_government_contractors_take_note.html">SAM</a>, request a <a target="_blank" href="http://fedgov.dnb.com/webform/index.jsp">D-U-N-S number</a>, and take care of some <a target="_blank" href="http://sisarina.com/blog/how-to-best-work-with-government-agencies">other paperwork</a>. You’ll also need to know where to find opportunities: <a target="_blank" href="https://www.fbo.gov/">FedBizOpps</a>. A search of this central repository can give you an idea of the government’s needs in your specialty area, and what might be required for a successful bid.</p>
<p>However you proceed, be advised that patience is key; expect to wait months before contract winners are notified. Start slowly, and find a mentor or business partner who can help you along the way.</p>
<p><em>A version of this article was originally published on the <a target="_blank" href="http://sisarina.com/blog/what-is-government-contracting">Sisarina blog</a></em>.</p>
<p><span style="font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 16px;"><strong>Learn more:</strong></span></p>
<p><span style="font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 16px;"><strong> </strong></span>System for Award Management (<a target="_blank" href="https://www.sam.gov/portal/public/SAM">SAM</a>)</p>
<p>Keep up with ever-evolving federal guidelines with Washington Business Journal’s <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/">FedBizDaily</a>, available online and via email</p>
<p>More <a target="_blank" href="../../ds/11647/53517-government_contracting_resources.html">government contracting resources</a></p>
<p><span style="font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 16px; font-weight: bold;">Team with us:</span></p>
<p>DynPort is actively looking for teaming partners with novel nerve agent countermeasures and broad-spectrum host-directed therapeutics for potential government contract work. Please <a target="_blank" href="../../registrations/546.html">contact</a> Mike McGinnis or call 301-607-5245 if you are interested in discussing these opportunities.</p>
<hr />
<h2></h2>
<h2><span style="color: #005884;"><strong>TechWatch: Science News Tidbits</strong></span></h2>
<p><a target="_blank" href="http://www.fiercedrugdelivery.com/story/pollen-delivers-vaccine-rather-sneeze/2012-11-28#ixzz2DeD6OMej">DARPA explores using pollen grains to deliver oral vaccines</a><br /><a target="_blank" href="http://www.fiercedrugdelivery.com/story/pollen-delivers-vaccine-rather-sneeze/2012-11-28#ixzz2DeD6OMej"><img style="float: right; margin: 10px;" alt=" Tiny pollen spores can be crushed, cleaned and then filled with vaccine as future vaccine pills in a U.S. military-funded project. Credit: DARPA/Dr. Harvinder Gill " src="http://assets1.csc.com/dvc/images/pollen_vaccine_pills_02.gif" height="299" width="300" /></a>“Pollen is normally just a frustration for those of us with hay fever, but it could actually turn out to be a lifesaver. A research project at the U.S. Defense Advanced Research Projects Agency (DARPA) is looking at turning pollen grains into a delivery system for oral vaccines. Harvinder Gill, an assistant professor of chemical engineering at Texas Tech University who is sponsored through DARPA's Young Faculty Awards (YFA) program, is developing a pollen-based oral vaccination platform in order to create a vaccine that is easy to transport and easy to take, needing no specialist medical training. This is particularly important for troops deployed in remote areas and for people living in areas where medical support is hard to come by.” <em>(Source: Suzanne Elvidge, FierceDrugDelivery)</em></p>
<p><em>Image: Tiny pollen spores can be crushed, cleaned and then filled with vaccine as future vaccine pills in a U.S. military-funded project. Credit: DARPA/Dr. Harvinder Gill</em></p>
<p><a target="_blank" href="http://www.fda.gov/BiologicsBloodVaccines/ScienceResearch/ucm329286.htm?source=govdelivery">Firefly chemistry used to evaluate tuberculosis vaccines</a><br /> “The results of a study by Food and Drug Administration (FDA) scientists suggest that a laboratory test based on firefly chemistry could accurately and rapidly evaluate the potency of tuberculosis vaccines in triggering immune responses. The findings are important because the new test might be able to replace the existing one, which is time-consuming, labor intensive, and often does not yield reproducible results. Additional studies are underway to further evaluate the findings to determine the adoptability of this test. This test has the potential to facilitate the production process of current tuberculosis vaccines while enabling development of newer vaccines now being studied in the laboratory.” <em>(Source: FDA)</em></p>
<p><strong>Journal article, from the <em>Journal of Microbiological Methods</em></strong> (full text requires a subscription): <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0167701212002047">Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations</a></p>
<p><a target="_blank" href="http://arstechnica.com/science/2012/11/self-boosting-vaccine-could-give-single-shot-immunity/">Self-boosting vaccine could give single-shot immunity</a><br /> "A self-boosting vaccine would, with a single dose, give people regular re-exposure to the proteins of dangerous infectious agents possibly handling several risks with a single dose. The downside? The method would involve giving the vaccine's recipients a lifelong viral infection. Of course, many people already have these infections. Herpes viruses and cytomegalovirus often set up shop in human cells without causing any symptoms for years. But they also sporadically come out of hiding (rather famously in the case of the herpes family) and start a brief flare up. Although the immune system can clear the active infection, it never manages to eliminate the reservoir of quiescent virus hiding out in some cells.” <em>(Source: ARS Technica)</em></p>
<p><strong>Journal article, from <em>Proceedings of the National Academy of Sciences (PNAS) of the United States</em></strong> (full text requires a subscription): <a target="_blank" href="http://www.pnas.org/content/early/2012/11/14/1209683109">Self-boosting vaccines and their implications for herd immunity</a></p>
<hr />
<h2></h2>
<h2><span style="color: #005884;"><strong>Industry and Government Contracting News</strong></span></h2>
<h3><span style="color: #005884;"><strong>Biopharma and Biodefense</strong></span></h3>
<p><a target="_blank" href="http://www.fiercedrugdelivery.com/story/porcupine-quills-point-less-painful-shots/2012-12-11"><img style="float: right; margin: 10px;" alt="Porcupine on a log eating berries (iStockphoto)" src="http://assets1.csc.com/dvc/images/porcupine.gif" height="133" width="200" /></a>For less painful shots, scientists look to... <a target="_blank" href="http://www.fiercedrugdelivery.com/story/porcupine-quills-point-less-painful-shots/2012-12-11">porcupines</a>?<br /> <strong>Journal abstract, from <em>PNAS</em>:</strong> <a target="_blank" href="http://www.fiercedrugdelivery.com/story/porcupine-quills-point-less-painful-shots/2012-12-11">Microstructured barbs on the North American porcupine quill enable easy tissue penetration and difficult removal</a></p>
<p>FDA has approved raxibacumab injection to treat inhalational anthrax; it was the first monoclonal antibody to be <a target="_blank" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332341.htm">licensed</a> under the FDA Animal Efficacy Rule, and the first licensed drug produced by the <a target="_blank" href="http://www.nti.org/gsn/article/fda-offers-first-license-drug-produced-bioshield-program/?utm_source=BNT,+December+18,+2012&utm_campaign=BNT121812&utm_medium=email">BioShield</a> program.</p>
<p>“In a first for any infectious disease, a <a target="_blank" href="http://www.newscientist.com/article/dn22529-new-vaccine-may-give-lifelong-protection-from-flu.html">vaccine</a> against flu has been made out of messenger RNA (mRNA) – the genetic material that controls the production of proteins. Unlike its predecessors, the new vaccine may work for life, and it may be possible to manufacture it quickly enough to stop a pandemic.” (from <em>New Scientist</em>)<br /> <strong>Journal article, from <em>Nature Biotechnology</em></strong> (subscription required for full text): <a target="_blank" href="http://www.nature.com/nbt/journal/v30/n12/full/nbt.2436.html">Protective efficacy of<em> in vitro </em>synthesized, specific mRNA vaccines against influenza A virus infection</a></p>
<p>Ever wonder what goes on at <a target="_blank" href="http://www.westhartfordnews.com/articles/2012/11/18/news/doc50a9052a7b20c985515626.txt?viewmode=fullstory">Plum Island</a>?</p>
<p>As more cases of new SARS-like virus are confirmed; authorities are <a target="_blank" href="http://www.cbc.ca/news/health/story/2012/11/23/coronavirus-sars-who-confirmed.html?cmp=rss&utm_source=BNT,+November+26,+2012&utm_campaign=BNT112612&utm_medium=email">investigating</a> person-to-person spread. The novel coronavirus most <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/other/sars/news/nov2012corona.html">closely resembles</a> a strain found in bats. <a target="_blank" href="http://www.who.int/csr/disease/coronavirus_infections/faq_dec12/en/index.html?utm_source=BNT,+December+3,+2012&utm_campaign=BNT120312&utm_medium=email">What you need to know</a> about the new novel coronavirus, from WHO.</p>
<p><a target="_blank" href="http://www.niaid.nih.gov/topics/westNile/Pages/default.aspx"><img style="float: right; margin: 10px; border: 1px solid black;" alt=" Screenshot: NIAID West Nile Virus information site" src="http://assets1.csc.com/dvc/images/NIAID_West_Nile_site.gif" height="190" width="300" /></a>Belgian company <a target="_blank" href="http://www.examiner.com/article/belgium-company-discovers-a-new-class-of-antibiotics-treats-all-mrsa-strains">discovers</a> a new class of antibiotics that may offer treatment against multiple drug-resistant infections. Taking a different approach, <a target="_blank" href="http://blogs.scientificamerican.com/observations/2012/11/29/real-time-genetics-could-squash-superbug-outbreaks-before-they-spread/">real-time genetics</a> could squash superbug outbreaks before they spread.</p>
<p>NIAID has launched a new <a target="_blank" href="http://www.niaid.nih.gov/topics/westNile/Pages/default.aspx">West Nile virus information center</a> on its website, and WHO will <a target="_blank" href="http://www.who.int/csr/don/en/index.html?utm_source=BNT,+November+21,+2012&utm_campaign=BNT112112&utm_medium=email">change</a> the way it reports H5N1 cases (<a target="_blank" href="http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/index.html">new WHO page</a>).</p>
<p>Virus found in dogs may <a target="_blank" href="http://www.fiercevaccines.com/story/virus-found-dogs-may-fuel-new-vaccines/2012-11-28">fuel</a> new vaccines.<br /> <strong>Journal article, from <em>PLOS One</em>:</strong> <a target="_blank" href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0050144">Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5</a></p>
<p>Military <a target="_blank" href="http://www.popsci.com/technology/article/2012-11/military-uniforms-future-will-automatically-turn-chemical-suits-presence-threats?cmpid=tw">uniforms of the future</a> will automatically turn into chemical suits in the presence of threats.</p>
<p><em>Yersinia pestis</em>: <a target="_blank" href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0049803?utm_source=BNT,+December+4,+2012&utm_campaign=BNT120412&utm_medium=email">new evidence for an old infection</a>, from <em>PLoS One</em>.</p>
<p>DARPA tackles the <a target="_blank" href="http://www.fiercevaccines.com/story/darpa-tackles-dna-vaccine/2012-12-06">DNA vaccine</a>, and a new <a target="_blank" href="http://news.cnet.com/8301-17938_105-57558270-1/bleeding-internally-seal-it-with-this-darpa-foam/">foam</a> to stop internal bleeding.</p>
<p><a target="_blank" href="http://www.washingtonpost.com/national/health-science/research-on-stricken-bats-may-help-aids-fight/2012/12/09/8cc93ab8-38cc-11e2-b01f-5f55b193f58f_story.html?wpisrc=nl_headlines">Research</a> on stricken bats may help in the fight against AIDS.<br /> <strong>Journal abstract, from <em>Virulence</em>:</strong> <a target="_blank" href="http://pubs.er.usgs.gov/publication/70040528">Pathology in euthermic bats with white nose syndrome suggests a natural manifestation of immune reconstitution inflammatory syndrome</a></p>
<p>“About <a target="_blank" href="http://www.homelandsecuritynewswire.com/dr20121205-predicting-preventing-and-controlling-pandemics?utm_source=BNT,+December+5,+2012&utm_campaign=BNT120512&utm_medium=email">60 percent</a> of infectious diseases are caused by viruses, bacteria, and other pathogens that make the jump to humans from other species. This includes some of the most devastating disease outbreaks of the past thirty years, including HIV/AIDS, Ebola, and SARS. Despite the huge and rising toll of such diseases, many gaps remain in our understanding of how these “zoonoses” evolve, develop, and spread — gaps that must be filled if we are to succeed in preventing or at least reducing the impact of a next pandemic.” (Source: <em>Homeland Security Newswire</em>)<br /> <strong>Journal abstract, from <em>The Lancet</em>:</strong> <a target="_blank" href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61684-5/abstract">Prediction and prevention of the next pandemic zoonosis</a></p>
<p><a target="_blank" href="http://www.slate.com/articles/health_and_science/pandemics/2012/12/koala_pandemic_genetics_viruses_have_inserted_themselves_into_the_human.single.html"><img style="float: left; margin: 10px;" alt="Koala on a branch. Taken in the Lone Pine Koala Sanctuary, Australia. (iStockphoto)" src="http://assets1.csc.com/dvc/images/koala.gif" height="200" width="150" /></a><span style="font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 13px;"> </span></p>
<p>If simian hemorrhagic fever virus jumps species, the fallout could be catastrophic… but if it doesn’t, it could <a target="_blank" href="http://www.usnews.com/news/articles/2012/11/24/virus-more-deadly-and-untreatable-than-ebola">yield clues</a> about how to treat Ebola.</p>
<p>Past pandemics are in our genes: What <a target="_blank" href="http://www.slate.com/articles/health_and_science/pandemics/2012/12/koala_pandemic_genetics_viruses_have_inserted_themselves_into_the_human.single.html">koalas</a> can teach us about human evolution and disease.</p>
<p>In clinical news, FDA gives the <a target="_blank" href="http://medcitynews.com/2012/12/fda-gives-go-ahead-for-phase-2-trial-using-remote-monitoring-for-multiple-sclerosis-drug/#ixzz2FbkK6yRd">go ahead</a> for a Phase 2 trial using remote monitoring and crowd-sourcing, and people with certain <a target="_blank" href="http://www.the-scientist.com/?articles.view/articleNo/33300/title/Personality-Predicts-Placebo-Effect/">personality traits</a> are more likely to get pain relief from a placebo.</p>
<p>Finally in the "good names for a band category," Antigenic Subversion: <a target="_blank" href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003065?utm_source=BNT,+December+18,+2012&utm_campaign=BNT121812&utm_medium=email">A Novel Mechanism of Host Immune Evasion by Ebola Virus</a> (from <em>PLoS Pathogens</em>).</p>
<h3><span style="color: #005884;"><strong>Government Contracting and Business</strong></span></h3>
<p>RWJF Scholar in Health Policy Research Rachel Kahn Best explores the <a target="_blank" href="http://www.rwjf.org/en/research-publications/find-rwjf-research/2012/11/the-politics-of-disease-research.html.html?cid=xtw_humancap">impact of advocacy</a> on federal funding for medical research. “"Increases in the number of nonprofits and lobbying expenditures are both significantly associated with increases in research funding, with each $1,000 spent on lobbying associated with a $25,000 increase in research funds the following year."</p>
<p>The devil in the details: missing a <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/12/missing-a-small-detail-could-mean.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-12-07&page=all">small detail</a> could mean losing a big contract. “Government agencies are held to a high standard and must comply with the strict requirements of procurement law and regulation. Likewise, contractors are held to a high standard of attention to detail, and failure to meet that standard will result in offers being rejected and losing bid protests.” More on <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/12/forecasting-your-federal-contract.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-12-04">forecasting</a> your federal contracting success.</p>
<p>With new biosafety <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/bt/bioprep/news/dec1312select.html?utm_source=BNT,+December+14,+2012&utm_campaign=BNT121412&utm_medium=email">rules</a>, few public health labs will handle the riskiest agents.</p>
<p>Interested in marketing your products down under? New Zealand and Australia regulatory authorities to <a target="_blank" href="http://www.raps.org/focus-online/news/news-article-view/article/2596/merger-of-australian-new-zealand-regulatory-agencies-on-track-officials-say/utm_source/social/utm_medium/twitter/utm_campaign/rfnews.aspx">merge</a>.</p>
<p>In regulatory news, FDA <a target="_blank" href="http://www.fiercebiotech.com/story/fda-matches-most-new-drug-approvals-years-2012-it-enough/2012-12-06#ixzz2EJCzdsGh">matches</a> the most new drug approvals in years in 2012, while under <a target="_blank" href="http://www.nature.com/news/fda-under-pressure-to-relax-drug-rules-1.11936">pressure</a> to relax drug rules to facilitate development of new antibiotics.</p>
<p><strong>Draft guidance:</strong> FDA issued this draft guidance in December: <a target="_blank" href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM332181.pdf">Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products</a> (PDF, 997K)</p>
<p>Silicon Valley Congressman Mike Honda (D-CA) <a target="_blank" href="http://mobihealthnews.com/19332/details-bill-that-calls-for-mobile-health-office-at-fda/">introduced a bill</a> that, among other things, seeks to create an Office of Wireless Health at the FDA, as a company finalizes plans to launch a tricorder-like <a target="_blank" href="http://www.technologyreview.com/news/507886/a-gadget-that-makes-you-the-doctor/?utm_source=BNT,+November+30,+2012&utm_campaign=BNT113012&utm_medium=email">self-diagnostic device</a> that works with your smartphone.</p>
<p>The U.S. Army Edgewood Chemical Biological Center (ECBC), and the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) opened a new <a target="_blank" href="http://globalbiodefense.com/2012/11/29/army-opens-new-proteomics-core-lab-for-cbrne-research/?utm_source=rss&utm_medium=rss&utm_campaign=army-opens-new-proteomics-core-lab-for-cbrne-research">Proteomics Core Facility</a> at Aberdeen Proving Ground, MD.</p>
<p>Join a Tufts Center for the Study of Drug Development study to benchmark clinical contracting and legal processes. Deadline to <a target="_blank" href="http://csdd.tufts.edu/sponsored_research">participate</a> is <strong>January 7, 2013</strong>.</p>
<h3></h3>
<h3><span style="color: #005884;"><strong>Reports and Resources</strong></span></h3>
<p><strong><a target="_blank" href="http://www.phe.gov/Preparedness/mcm/phemce/Documents/2012-PHEMCE-Implementation-Plan.pdf"><img style="float: right; margin: 10px;" alt="Report cover: Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan (PDF, 521K) " src="http://assets1.csc.com/dvc/images/PHEMCE_plan_cover.gif" height="259" width="200" /></a>Report:</strong> Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan - <a target="_blank" href="http://www.phe.gov/Preparedness/mcm/phemce/Documents/2012-PHEMCE-Implementation-Plan.pdf">full plan</a> (PDF, 521K) and one-page <a target="_blank" href="http://www.phe.gov/Preparedness/mcm/phemce/Documents/phemce-ip-factsheet.jpg.pdf">fact sheet</a> (PDF, 102K)</p>
<p><strong>Report:</strong> <a target="_blank" href="http://mbio.asm.org/content/3/6/e00494-12.full">Emerging Infectious Diseases in 2012</a>: 20 Years after the Institute of Medicine Report, by NIAID’s Dr. David M. Morens and Dr. Anthony S. Fauci</p>
<p><strong>Workshop summary:</strong> <a target="_blank" href="http://www.iom.edu/Reports/2012/The-Social-Biology-of-Microbial-Communities.aspx">The Social Biology of Microbial Communities</a> (Institute of Medicine)</p>
<p><strong>Editorial round-up:</strong></p>
<ul>
<li>Americans depend on a strong CDC (<a target="_blank" href="http://www.politico.com/news/stories/1112/84286.html#ixzz2DdSwpDrN?utm_source=BNT,+November+29,+2012&utm_campaign=BNT112912&utm_medium=email">Politico</a>)</li>
<li>Curing cancer by throwing spaghetti at the wall - increasing innovation in federal research (<a target="_blank" href="http://www.bio-itworld.com/2012/11/30/curing-cancer-throwing-spaghetti-at-wall.html">Skeptical Outsider</a>/Bio-IT World)</li>
<li>Let’s gang up on killer bugs (<a target="_blank" href="http://www.nytimes.com/2012/12/10/opinion/teaming-up-to-make-new-antibiotics.html?_r=1&">New York Times</a>)</li>
<li>How vaccines save lives, grow economies (GAVI Alliance)</li>
<li>Lessons from vaccine history (<a target="_blank" href="http://www.nature.com/nm/journal/v18/n12/full/nm.3039.html?WT.ec_id=NM-201212&utm_source=BNT,+December+7,+2012&utm_campaign=BNT120712&utm_medium=email">Nature</a>)</li>
</ul>
<p> </p>
<p><strong>Awards:</strong> Nominate vaccine industry colleagues and companies in India for the Vaccine Outstanding Achievement Awards. <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineOutstandingAchievementAwards-NominationForm">Nominations</a> due by <strong>January 14, 2013</strong>.</p>
<p><strong>Infographic:</strong> <a target="_blank" href="http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm295473.htm">FDA drug approval process</a>, from CDER</p>
<p><strong>Blog:</strong> A new blog from PLoS: <a target="_blank" href="http://blogs.plos.org/publichealth/">Public Health</a></p>
<p><strong>Book:</strong> <a target="_blank" href="http://www.upmc-biosecurity.org/website/resources/publications/2012/2012-12-12-prep_bioterrorism.html?utm_source=BNT,+December+12,+2012&utm_campaign=BNT121212&utm_medium=email#pdf">Preparing for Bioterrorism</a>: The Alfred P. Sloan Foundation’s Leadership in Biosecurity (free PDF available)</p>
<p><strong>Video (2:35):</strong> <a target="_blank" href="http://www.npr.org/blogs/health/2012/12/13/167188333/herbs-and-empires-a-brief-animated-history-of-malaria-drugs?ft=1&f=103537970&utm_medium=twitter&utm_source=twitterfeed">Herbs And Empires</a>: A Brief, Animated History Of Malaria Drugs</p>
<p><strong>Coloring book:</strong> Download a Flu Fighter <a target="_blank" href="http://www.flufacts.com/pdf/FluFighter_Coloring_Book.pdf">coloring book</a> (PDF, 4.6MB), produced by the National Foundation for Infectious Diseases (NFID) and National Association of School Nurses</p>
<hr />
<h2></h2>
<h2><span style="color: #005884;"><strong>Upcoming Events</strong></span></h2>
<p><strong>January 21-25, 2013, Palm Springs, CA –</strong> <a target="_blank" href="http://www.chi-peptalk.com/">Pep Talk</a>: The Protein Science Week – now accepting <a target="_blank" href="http://www.chi-peptalk.com/peptalk_content.aspx?ekfrm=116231">speaker applications</a></p>
<p><strong>January 22, 2013, Rockville, MD –</strong> <a target="_blank" href="https://www.techcouncilmd.com/events/events_showEvent.php?evt_id=468&utm_source=iContact&utm_medium=email&utm_campaign=TCM%20Events&utm_content=">MdBio Leadership Series</a>: Continuing the Dialog with the FDA – Breakfast with Senior FDA Officials from CDER, CDRH and CBER</p>
<p><strong>January 24-25, 2013, Arlington, VA – 3rd Annual <a target="_blank" href="http://www.exlpharma.com/clinicalCAPA">Developing CAPAs in the GCP Environment</a></strong></p>
<p><strong>January 28-30, 2013, Washington, DC </strong>–<a href="http://www.vaccine-forum.com/">Phacilitate Vaccine Forum</a> Washington, co-located with the <a target="_blank" href="http://www.proteins-forum.com/">Protein Therapeutics Forum</a> and <a target="_blank" href="http://www.cgt-forum.com/">Cell &amp; Gene Therapy Forum</a></p>
<p><strong>January 30 - February 2, 2013, Raleigh, NC – </strong><a target="_blank" href="http://scienceonline.com/">Science Online2013</a>: Conversation, Community, &amp; Connections at the Intersection of Science &amp; the Web</p>
<p><a style="font-size: 13px; font-family: Arial, Verdana, Helvetica, sans-serif;" target="_blank" href="http://www.scopesummit.com/"><img style="float: right; margin: 10px;" alt="Miami Beach view of pastel Art Deco buildings with palm trees and bright blue sky" src="http://assets1.csc.com/dvc/images/miami_beach_art_deco.gif" height="166" width="250" /></a></p>
<p><strong>February 4-8, 2013, Boston, MA </strong>– <a target="_blank" href="http://csdd.tufts.edu/courses/postgraduate_course">Postgraduate Course</a> in Clinical Pharmacology, Drug Development and Regulation</p>
<p><strong>February 5, 2013, Somerset, NJ –</strong> <a target="_blank" href="http://www.huntingdon.com/usbio2013/">3rd Annual Biologics Symposium</a> (complimentary, registration required)</p>
<p><strong><strong>February 5-7, 2013, Miami, FL – </strong></strong>4th Annual Summit for Clinical Ops Executives (SCOPE)</p>
<p><strong>February 6-7, 2013, London, UK –</strong> Clinical Outsourcing World Europe</p>
<p><strong>February 11-12, 2013, San Francisco, CA – </strong>Genomics in Medicine (part of Molecular Med Tri-Con) - speaker proposals now being accepted</p>
<p><strong>February 20-21, 2013, Washington, DC –</strong> Marketing Pharmaceuticals 2013: Workshop for Regulatory/Legal/Communications Professionals and Promotional Review Teams</p>
<p><strong>February 21, 2013, Boston, MA –</strong> Tufts CSDD Executive Forum: Managing Protocol Design to Improve Clinical Study Efficiency</p>
<p><strong>March 5-7, 2012, Pune, India –</strong> Vaccine World Summit India 2013 – speaker abstracts now being accepted</p>
<p><strong>March 8 -10, 2013, Chicago, IL – </strong>NFID 2013 Clinical Vaccinology Course</p>
<p><strong><img style="float: right; margin: 10px;" alt=" Baltimore waterfront" src="http://assets1.csc.com/dvc/images/BaltimoreWaterfront2.gif" height="168" width="250" />March 11-13, 2012, Rosslyn, VA – </strong>International Society for BioProcess Technology ISBioTech 3rd Annual Meeting, including Baculovirus Expression Technology and Viral Vectors &amp; Vaccines tracks - call for papers and posters now open</p>
<p><strong>March 18-20, 2013, Baltimore, MD – </strong>14th Annual <a target="_blank" href="http://www.iirusa.com/immunogenicity/home.xml">Immunogenicity for Biotherapeutics</a> - register by <strong>January 11, 2013</strong> to save $400</p>
<p><strong>April 22-24, 2013, Baltimore, MD – </strong>NFID 16th Annual <a target="_blank" href="http://www.cvent.com/events/16th-annual-conference-on-vaccine-research/event-summary-db97bedd5ee041eeb09d971650f76be0.aspx">Conference on Vaccine Research</a></p>
<p><strong>April 22-25, 2013, Chicago, IL –</strong> <a target="_blank" href="http://convention.bio.org/">BIO International Convention</a></p>
<p><strong>April 29-May 3, 2013, Boston, MA – </strong><a target="_blank" href="http://www.pegsummit.com/">9th Annual PEGS</a>, the Essential Protein Engineering Summit</p>
<p><strong>May 9-10, 2013, San Diego, CA – </strong>7th Annual <a target="_blank" href="http://knowledgefoundation.com/viewevents.php?event_id=291&act=evt&utm_source=Campaigner&utm_campaign=Sample_Prep_Call_for_Speakers&campaigner=1&utm_medium=HTMLEmail">Sample Prep 2013</a> - <a target="_blank" href="http://knowledgefoundation.com/become_speaker.php">speaker abstracts</a> accepted until <strong>January 4, 2013</strong></p>
<p><strong>May 14-16, 2013, Seattle, WA – </strong><a target="_blank" href="http://www.ibclifesciences.com/bioassays/overview.xml">Development, Validation and Maintenance of Biological Assays</a> - register by <strong>January 18, 2013</strong> to save $500</p>
<p><strong>May 29-31, 2013, Silver Spring, MD –</strong> FDA’s Medical Countermeasures initiative (MCMi)  2nd annual Regulatory Science Symposium – <a target="_blank" href="http://www.fda.gov/EmergencyPreparedness/MedicalCountermeasures/ucm330195.htm">now accepting topic suggestions</a></p>
<p><strong>June 18-19, 2013, Washington, DC area –</strong> 21st <a target="_blank" href="http://www.knowledgefoundation.com/viewevents.php?event_id=290&act=evt&utm_source=Campaigner&utm_campaign=Biodetection_2013_Call_for_Speakers&campaigner=1&utm_medium=HTMLEmail">Biodetection Technologies</a> - <a target="_blank" href="http://knowledgefoundation.com/become_speaker.php">speaker abstracts</a> accepted until <strong>January 14, 2013</strong></p>
<p><strong>June 23-27, 2013, Boston, MA –</strong> <a target="_blank" href="http://www.diahome.org/en/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?ProductID=30075&EventType=Annual%20Meeting">DIA 49th Annual Meeting</a> - Advancing Therapeutic Innovation and Regulatory Science - <a target="_blank" href="http://www.diahome.org/Get-Involved/Submit-Abstracts/Submit-a-New-Abstract/Select-Meeting.aspx">call for posters</a>, due <strong>February 28, 2013</strong></p>
<hr />
<h2><span style="color: #005884;"><strong>Work With Us</strong></span></h2>
<p><strong><a target="_blank" href="../../ds/16190/16330-small_business_procurement.html"><img style="float: right; margin-left: 10px; margin-right: 10px;" alt="&quot;Open&quot; sign next to door of small business" src="http://assets1.csc.com/dvc/images/open_smallbiz_sm.gif" height="133" width="200" /></a>Small business procurement:</strong> <a target="_blank" href="../../ds/16190/16330-small_business_procurement.html">What we buy</a>... and what we don't. If you're a small business offering the services we're looking for, please <a target="_blank" href="../../registrations/546.html">let us know</a>.</p>
<p><strong>Team with us: </strong>DynPort can help you apply your technology to new programs, or advance your product from proof-of-concept into clinical trials. <a target="_blank" href="../../ds/16190/16326-team_with_dvc.html">Learn more</a></p>
<p><a target="_blank" href="https://twitter.com/dynport">Follow us on Twitter</a> for the latest, including job openings.</p>
<hr />
<p><a target="_blank" href="http://twitter.com/dynport"><img src="http://assets1.csc.com/dvc/images/twitter2.png" alt="Follow us on Twitter" height="27" width="160" /></a> <a target="_blank" href="http://www.linkedin.com/company/dynport-vaccine-company-llc-a-csc-company"><img src="http://assets1.csc.com/dvc/images/linkedin.png" alt="Follow us on LinkedIn" height="27" width="158" /></a> <a target="_blank" href="../28826-bugs_and_drugs.html"><img src="http://assets1.csc.com/dvc/images/Blog_Button_small.jpg" alt="DVC Bugs and Drugs Blog" height="27" width="160" /></a></p>
<p> </p>
<p>View previous editions of this newsletter in our <a target="_blank" href="../41185-dvc_news_updates_for_partners.html">archive</a> or learn more about DVC on our <a target="_blank" href="../../../dvc.html">website</a>.</p>
<p><span style="color: #850057;">Like this newsletter? Plan to attend one of the events above? Have an idea for a topic we should cover? Let us know in the comments below!</span></p>
<p><em>DVC is not necessarily affiliated with third parties listed in this newsletter, nor does linking imply endorsement. The information herein is provided as a service for informational purposes only.</em></p>
<p>We'd love to hear from you! Feel free to comment below. Due to corporate policy, comments are moderated--we approve them during business hours Monday through Friday.</p>
<div id="_mcePaste" style="position: absolute; width: 1px; height: 1px; overflow: hidden; top: 0px; left: -10000px;">How to get more from your trade show investment</div></p>
    </section>
    </article>
		<div id="gigyaReactionsHolder"></div>


<div id="commentsPrefix"><div>COMMENTS</div></div>
<div id="gigyaSpecificityOverloader" class="gso"><div id="gigyaCommentsHolder"></div></div>


<script>
var delayedLoadComments = function () {
  //Setting up some vars used by all of the following Gigya plugins
  var defaultUserAction = new gigya.socialize.UserAction();
  defaultUserAction.setTitle(document.title);
  defaultUserAction.setLinkBack(window.location);

  var urlParts = window.location.pathname.split('/');
  var urlSlug = urlParts[urlParts.length -1].split('#')[0].split('?')[0];


  //########START REACTIONS########
  var textReactions=[
    {
      text: '',
      ID: 'thumbs_up',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_up.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_up.png',
      tooltip:'I give this article my thumbs up!',
      feedMessage: 'Thumbs Up!',
      headerText:'You give this article a thumbs up'
    }
    ,{
      text: '',
      ID: 'thumbs_down',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_down.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_down.png',
      tooltip:'I give this article my thumbs down.',
      feedMessage: 'Thumbs Down',
      headerText:'You give this article a thumbs down'
    }
  ];
  // Step 3: Define the Reactions Plugin's params object
  var reactionParams ={
    disabledProviders: 'twitter',
    barID: urlSlug, //  Identifier of the content to which this reaction refers
    containerID: 'gigyaReactionsHolder',  // Reactions Plugin DIV Container
    reactions: textReactions,  // The reaction array from Step 1
    userAction: defaultUserAction,  // The UserAction object from Step 2
    bodyText: 'Share it with your friends:', // optional - text that appears in the Share popup
    showCounts: 'top', // optional - displays the counters on top of the buttons
    cid:'',
    onReactionClicked:gigyaEventHandlers.onReactionClicked,
    onSendDone:gigyaEventHandlers.onSendDone
  };
  // Step 4: Load the Reactions Plugin:
  gigya.socialize.showReactionsBarUI(reactionParams);
  //########END REACTIONS########

  
  //########START COMMENTS########
  var commentsTemplates = {
    loginCanvas_loggedIn: '<div class="gig_photoHolder">$photoDiv</div><div class="gig_username">$username</div><div class="gig_logout"><a href="/utils/logout_visitor">Log&nbsp;Out</a></div>',
    loginCanvas_loggedOut:'<div class="gig_photoHolder"><img src="/images/new/icons/comment_default_user_icon.png" width="48" height="48" alt=""></div><div class="gig_loginmessage"><h3>Post a new comment</h3><p>You must be logged in to post comments.</p></div><div class="gig_login"><a href="javascript:void(0);" onclick="accountPopupWindow(\'account_login\');"><img src="/images/new/icons/comment_login_button.png" width="144" height="24" alt="Login"></a></div>'
  };
  //Good browsers get '100%', and Gigya's internals turn this number plus some math into 'NaNpx',
  //which is applied to the `width` value of the style attribute on EVERY ELEMENT GIGYA TOUCHES.
  //As 'NaNpx' is an invalid CSS width value, all of Gigya's width values fail, and mine take precedence.
  //IE7 & 8 try someElement.style.width = (NaN) + 'px' and error out, breaking the whole showCommentsUI invocation.
  //No responsive comments for IE7 or 8!
  var gigyaCommentsWidth = '100%';
  if($.browser.msie === true && ($.browser.version === '8.0' || $.browser.version === '7.0')){
    gigyaCommentsWidth = 640;
  }
  var showCommentsParams ={
    categoryID: "Unmoderated",
    streamID: "93730",
    useSiteLogin: true,
    onSiteLoginClicked: gigyaEventHandlers.onSiteLoginClicked,
    containerID: 'gigyaCommentsHolder',
    cid:'',
    templates: commentsTemplates,
    width:gigyaCommentsWidth,
    enabledShareProviders: 'facebook,yahoo,linkedin,pinterest',
    onSendDone: gigyaEventHandlers.onSendDone,
    onCommentSubmitted: gigyaEventHandlers.onCommentSubmitted,
    onLoad:function(){
      if(mobileDevice){
        myScroll.refresh();
      }
    }
  }
  gigya.socialize.showCommentsUI(showCommentsParams);
  //########END COMMENTS########
  
}
$csc().gigya.register(delayedLoadComments);
</script>
    </article>

  <aside class="sideBar">        
      <div>
        Welcome! Thanks for checking out news for our partners from
DynPort Vaccine Company LLC, a CSC company.<br><br>

We’ve been working in biopharmaceutical product development as a
government contractor since 1997, and have learned a few things along
the way. <strong>But... this newsletter isn't about us. </strong> <br><br>

Our goal is to share information with our partners and
potential partners, who may be interested in developments related to
government contracting and biopharmaceuticals.  (We send updates no more than once a month, so no need to worry about us overwhelming your inbox!)<br><br>

<strong>To receive these updates via email, <a href="../../ds/16190/41114-join_our_partners_e_mail_list.html"><strong>sign up here</strong></a>.</strong>  
      </div>
    </aside>
     </div>
</section>
      
<aside id="myRcmds">
  <header id="myRcmdsHeader">
    <div id="myRcmdsPersHeader"><strong>CSC Recommendations</strong></div>
    <div id="myRcmdsPersonalization">
      <div id="persIcon"><img src="../../../images/new/icons/comment_default_user_icon.png" alt=""></div>
      <div id="persButtons">
        <ul>
          <li id="myrecs_logout"><a href="../../../utils/logout_visitor.html">LOG OUT</a></li>
          <li id="myrecs_edit"><a onclick="accountPopupWindow('editprofile');" href="javascript:void(0);">EDIT PROFILE</a></li>
        </ul>
      </div>
      <div id="persProfile"><span id="myrecs_visitor_name"></span><span id="myrecs_job_title"></span></div>
    </div>
  </header>
  <div id="myRcmdsTrigger"><a id="myRcmdsChevronHolder"><span id="myRcmdsChevron">&laquo;</span></a></div>
  <section id="recs_content">
    <label>Recommended Reading</label>
    <div id="recs_div">

      <article class="contentNode">
        <a class="imgAnchor" href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="Changing the Way Banks Do Business" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html">Changing the Way Banks Do Business</a></strong><p>CSC and SAP together deliver end-to-end banking transformation with a portfolio of...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_success' height="50" width="50" alt="Coca-Cola Supply Chain Management Success Story" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html">Coca-Cola Supply Chain Management Success Story</a></strong><p>Coca-Cola has dominated the beverage market for over a century, yet still values...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="The Future of 3D Printing Services and Manufacturing" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html">The Future of 3D Printing Services and Manufacturing</a></strong><p>CSC explores the future of 3D printing and manufacturing, as 3D printing manufacturing...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_offer' height="50" width="50" alt="CSC CloudBill" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html">CSC CloudBill</a></strong><p>An on-demand billing and subscription management Software as a Service for digital...</p></section>
      </article>

    </div>
  </section>
</aside>
<script type="text/javascript">
  var f = true;
  var myrecs_rec = 'recs_item_va';
  var myrecs_param = 'entity.id=93730';
</script>

      <!-- Content End -->
      <footer>
        <div class="wrapper">

          <section id="relationsBucket">
            <nav>
              <ul>
                <li><a class="redTri" href="../../../about_us.html"><strong>ABOUT CSC</strong></a>
                </li>
                <li><a class="blueTri" href="../../../success_stories.html"><strong>SUCCESS STORIES</strong></a>
                </li>
                <li><a class="lightBlueTri" href="../../../careersus/flxwd/16005-careers.html"><strong>CAREERS</strong></a>
                </li>
                <li><a class="purpleTri" href="../../../global_alliances.html"><strong>GLOBAL ALLIANCES</strong></a>
                </li>
                <li><a class="yellowTri" href="../../../newsroom.html"><strong>NEWSROOM</strong></a>
                </li>
                <li><a class="greenTri" href="../../../investor_relations.html"><strong>INVESTOR RELATIONS</strong></a>
                </li>
              </ul>
            </nav>
          </section>

          <section id="newsEventsBucket">
                        <strong class="headline">
              CSC WIRE</strong>
            <nav>
              <ul>
<li><a href='../../../investor_relations/press_releases/106413.html'>CSC Delivers Continued Earnings, Margin and Cash Flow Growth</a></li>
<li><a href='../../../newsroom/press_releases/105673-hcl_technologies_and_csc_announce_strategic_partnership_to_address_the_application_modernization_market.html'>HCL Technologies and CSC Announce Strategic Partnership to Address the Application Modernization Market</a></li>
<li><a href='../../../newsroom/press_releases/105677-csc_to_host_investor_call_to_discuss_strategic_partnership_with_hcl_technologies_on_wednesday_january_15_2014.html'>CSC Hosts Investor Call to Discuss Strategic Partnership with HCL Technologies</a></li>

              </ul>
            </nav>
          </section>

          <section id="contactBucket">
            <div class="thumbBucket">
  <strong class="headline">
    Engage With Us</strong>
  <!-- comment to hide this section and reveal the following section -->

 <section>
    <aside>
      <a href="../../../townhall.html" class="townHall">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="../../../townhall.html">View On-Demand <br>Town Hall Events</a>
    </article>
  </section> 

  <!-- end townhall section -->
  <!-- uncomment following content for where there is a town hall.  Be sure to specify event title and include ref=blinkgif. -->
<!-- 
    <section>
    <aside>
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif" class="townHallLive">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif"><span class='alert'>Live Now in the Town Hall</span><br />How Will Regulatory Changes Impact Disaster Recovery?</a>
    </article>
  </section>
-->
  <!-- end live townhall section -->
  <section class="lef">
    <aside>
      <a href="../../../innovation.html" class="feedback">
        <!--img src="/images/new/icons/feedback.png" alt="Subscribe to our Newsletters" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="premiumContentPopupWindow({id: '7829', mediaType: 'newsletter', type: ''}); ">Get our Newsletters</a><br />
     </article>
  </section>

  <section>
    <aside>
      <a href="../../../engage_communities.html" class="community">
        <!--img src="/images/new/icons/communities.png" alt="CSC Communities" /--></a>
    </aside>
    <article>
      <a href="../../../engage_communities.html"> Join our Communities</a>
    </article>
  </section>

  <section class="feedbackSection">
    <aside>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);" id="engageWithUs" class="lef">
        <!--img src="/images/new/icons/forums.png" alt="Feedback" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);">Give Your Feedback</a>
    </article>
  </section>
</div>
          </section>

          <section id="socialBucket">
            <strong class="headline">
              Follow Us</strong>
            <nav class="social footer">
              <!-- Follow Bar plugin DIV container -->
              <div id="gigyaFollowFooter"></div>
              <div id="gigyaFollowFooterMobile">
                <ul>
                  <li><a href="http://www.facebook.com/pages/CSC/51414306171?v=app_101332539959471" class="facebook" target="_blank">&nbsp;</a></li>
                  <li><a href="http://twitter.com/#!/CSCNews" class="twitter" target="_blank">&nbsp;</a></li>
                  <li><a href="http://www.linkedin.com/company/csc" class="linkedin" target="_blank">&nbsp;</a></li>
                  <li><a href="../../../feeds.html" class="rss" target="_blank">&nbsp;</a></li>
                  <li><a itemprop="publisher" href="https://plus.google.com/118416213869891352236" class="googleplus clearText" target="_blank">CSC</a></li>
                </ul>
              </div>
              <ul>
                <li>
                  <a href="http://www.youtube.com/user/csc" target="_blank" class="youtube clearText">&nbsp;</a>
                </li>
              </ul>
            </nav>
          </section>
          <section id="corpBucket">
            <nav class="corpInfo">
              <ul>
  <li><a href="../../../legal.html">Legal</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../privacy.html">Privacy</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../site_map.html">Site Map</a>&nbsp; </li>
  <li>&copy; Computer Sciences Corp </li>
</ul>

            </nav>
          </section>
        </div>
      </footer>
    </div>
  </div>
  <!-- scripts -->
  <script type="text/javascript" src="http://www.google.com/jsapi?key=ABQIAAAAmQdrOgG-5AIXvyPvLF37UxSkoY0ZZixtVMJANGkGJlQelbG63hREfyZFOAPj93RuUqgytyCufo6x5Q">
</script>

<script type="text/javascript" src="http://assets2.csc.com/javascripts/googlefeedfetcher.js">

/***********************************************
* gAjax RSS Feeds Displayer- (c) Dynamic Drive (www.dynamicdrive.com)
* This notice MUST stay intact for legal use
* Visit http://www.dynamicdrive.com/ for full source code
***********************************************/

</script>

<style type="text/css">

.labelfield{ /*CSS for label field in general*/
color:brown;
font-size: 90%;
}

.datefield{ /*CSS for date field in general*/
color:gray;
font-size: 90%;
}

#example1 li{ 
margin-bottom: 8px;
padding-bottom: 8px;
margin-left:-28px;
text-indent:0px;
}
</style>
  <!-- end of scripts -->
  
</div>
 <script src="../../../javascripts/user/twistage_omniture-min-19b876fa394902ce781dfc20f23ba899.js" type="text/javascript"></script>
 <img src="http://a.company-target.com/pixel?id=1372868710&type=js" alt="pixel" style="display:none"/>
<img src="http://a.company-target.com/pixel?id=1372868656&type=js" alt="pixel" style="display:none"/>
 <script type="text/javascript">
    var _elqQ = _elqQ || [];
    _elqQ.push(['elqSetSiteId', '3015']);
    _elqQ.push(['elqTrackPageView']);
    
    (function () {
        function async_load() {
            var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true;
            s.src = '//img.en25.com/i/elqCfg.min.js';
            var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);
        }
        if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);
        else if (window.attachEvent) window.attachEvent('onload', async_load); 
    })();
</script>
</body>
</html>
